Intel Insights

Intel Releases 2023–24 Corporate Responsibility Report

Four years ago, Intel introduced its RISE strategy, laying out a decade-long framework for meeting benchmarks in responsibility, inclusion, sustainability, and enabling the digital world’s next generation. This week Intel released its 30th annual Corporate Responsibility Report, which outlines the progress made in 2023 and the beginning of 2024.

Explore the report

McAfee and Intel Showcase AI-Powered Deepfake Detection Technology at RSAC 2024

Cybercriminals often use AI to manipulate audio within videos to create alarmingly convincing deepfake scams. Introduced earlier this year, McAfee Deepfake Detector uses advanced AI detection to notify customers when audio has likely been generated or manipulated by AI. Now, by leveraging NPUs in Intel® Core™ Ultra processor-based PCs, performance in McAfee’s AI models has improved up to 300%.

"Technically Speaking" Podcast: The AI That Lives Inside Your PC

For as long as computers have been around, we’ve sought to make them faster, smarter, and more capable. So what new potential can AI promise? Imagine if every PC used AI to unleash new capabilities that benefit everyone, such as enhanced data security. In this episode, Intel’s Robert Hallock explores how PCs equipped with AI are transforming productivity and IT operations.

Listen to the episode

How Technology Is Transforming Collaboration and Innovation at Work

As cybercrime increases, protecting sensitive business data has become increasingly difficult and often leads to loss of both revenue and customers. In this session, Intel director of security ecosystem business development Todd Cramer discusses the current state of the cyberthreat landscape and how Intel is using AI to help companies mitigate those threats.

Learn more

QMed Asia Drives Early-Stage Cancer Detection Rate With Federated Learning

Despite its dual-tiered healthcare system—which offers a blend of universal coverage and choice-driven medical services—Malaysia still struggles in one key area: low rates of cancer detection. In this case study, learn how QMed collaborated with Intel and Taiwan-based JelloX Biotech Inc. to create a federated learning solution aimed at improving cancer diagnostics and screenings.